Abstract
The antitumoral effect of cisplatin [cis-diamminodichloroplatinum(II)] in mammals is related to its binding to DNA components. However, there is a lack of specific chemical methods to selectively detect those adducts formed in vivo at low concentrations. In this work, a new sensitive and selective method of determining cisplatin–DNA adducts based on the use of element-selective mass spectrometry is proposed, and the method is then applied to detect cisplatin adducts induced in vivo in somatic cells of Drosophila melanogaster. The bioanalytical strategy proposed here allows the determination of the most important DNA adduct formed between adjacent guanine units of the same DNA strand with cisplatin, and it is based on the coupling of capillary liquid chromatography (cap-LC) to inductively coupled plasma mass spectrometry (ICP-MS). This set-up allows the simultaneous monitoring of the Pt (from the drug) and P (from the DNA components) present in these adducts, once they have been cleaved by enzymatic hydrolysis of the DNA samples. Using this instrumental set-up, the adducts of cisplatin formed in vivo when D. melanogaster flies are exposed to different cisplatin concentrations can be detected and their concentration determined. The results obtained show a direct correlation between the concentration of cisplatin adducts, the induced genotoxic damage (measured as DNA strand breaks using the Comet assay) and the cisplatin concentration.
Similar content being viewed by others
References
Sherman SE, Lippard SJ (1987) Chem Rev 87:1153–1181
Yachnin JR, Wallin I, Lewensohn R, Sirzén F, Ehrsson H (1998) Cancer Lett 132:175–180
Jordan P, Carmo-Fonseca M (2000) Cell Mol Life Sci 57:1229–1235
Veal GJ, Dias C, Price L, Parry A, Errington J, Hale J, Pearson ADJ, Boddy AV, Newell DR, Tilby MJ (2001) Clin Cancer Res 7:2205–2212
Iijima H, Patrzyc HB, Dawidzik JB, Budzinski EE, Cheng H-C, Freund HG, Box HC (2004) Anal Biochem 333:65–71
Küng A, Strickman DB, Galanski M, Keppler B (2001) J Inorg Biochem 86:691–698
Iannitti-Tito P, Weimann A, Wickham G, Sheil MM (2000) Analyst 125:627–634
Franska M, Franski R, Schroeder G, Springer A, Beck S, Linscheid M (2005) Rapid Comm Mass Spectrom 19:970–974
Phillips DH (1997) Mutat Res 378:1–12
Edler M, Jakubowski N, Linscheid M (2006) J Mass Spectrom 41:507–516
Hann S, Zenker A, Galanski M, Bereuter TL, Stingeder G, Keppler BK (2001) Fresenius J Anal Chem 370:581–586
García Sar D, Montes-Bayón M, Blanco-González E, Sanz-Medel A (2006) J Anal Atom Spectrom 21:861–868
Pröfrock D, Leonhard P, Ruck W, Prange A (2005) Anal Bioanal Chem 381:194–204
Reardon JT, Vaisman A, Chaney SG, Sancar A (1999) Cancer Res 59:3968–3971
Tice RR, Agurell E, Anderson D, Burlison B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Environ Mol Mutagen 35:206–221
Fairbairn DW, Olive PL, O’Neill KL (1995) Mutat Res 339:37–59
Kassie F, Parzefall W, Knasmüller S (2000) Mutat Res 463:13–31
Collins AR (2004) Mol Biotech 26:249–261
Faust F, Kassie F, Knasmüller S, Boedecker RH, Mann M, Mersch-Sundermann V (2004) Mutat Res 566:209–229
Bilbao C, Ferreiro JA, Comendador MA, Sierra LM (2002) Mutat Res 503:11–19
Siddique H, Chowdhuri DK, Saxena DK, Dhawan A (2005) Mutagenesis 20:285–290
Vogel EW, Barbin A, Nivard MJM, Snack HF, Waters MD, Lohman PHM (1998) Mutat Res 400:509–540
Aguirrezabalaga I, Santamaría I, Comendador MA (1994) Mutagenesis 9:341–346
Gaivão I, Sierra LM, Comendador MA (1999) Mutat Res 440:139–145
Pastink A, Vreeken C, Nivard MJM, Searles LL, Vogel EW (1989) Genetics 123:123–127
Welters MJP, Fichtinger-Schepman AMJ, Baan RA, Jacobs-Bergmans AJ, Kegel A, van der Vijgh WJF, Braakhuis JM (1999) Br J Cancer 79:82–88
Nadin SB, Vargas-Roig LM, Drago G, Ibarra J, Ciocca DR (2006) Cancer Lett 239:84–97
Niedernhofer LJ, Lalai AS, Hoeijmakers JHJ (2005) Cell 123:1191–1198
Zamorano-Ponce E, Fernández J, Vargas G, Rivera P, Carballo MA (2004) Toxicol Lett 152:85–90
Jirsova K, Mandys V, Gispen WH, Bär PR (2006) Neurosci Lett 392:22–26
Kopjar N, Garaj-Vrhovac V, Milas I (2002) Carcinog Mutagen 22:13–30
Reardon JT, Vaisman A, Chaney SG, Sancar A (1999) Cancer Res 59:3968
Del Castillo Busto ME, Montes-Bayón M, Sanz-Medel A (2006) Anal Chem 78:8218–8226
Pereira Navaza A, Ruiz Encinar J, Sanz-Medel A (2007) Angew Chem Int Ed 46:569–571
Acknowledgements
The authors acknowledge the financial support from MEC of Spain (project CTQ2004-03005) as well as the support of Applied Biosystems with the instrumental setup.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
García Sar, D., Montes-Bayón, M., Aguado Ortiz, L. et al. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC–ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster . Anal Bioanal Chem 390, 37–44 (2008). https://doi.org/10.1007/s00216-007-1634-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1634-z